Transient Ischemic Attack

Clinical Trial Finder

Many patients who experience transient ischemic attacks (TIAs) are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Morbidity and Mortality in Patients With Hypertrophic Cardiomyopathy: a CALIBER Study

Condition:   Hypertrophic Cardiomyopathy
Intervention:   Other: No intervention
Sponsors:   University College, London;   Inherited Cardiac Diseases Unit, The Heart Hospital, London
Active, not recruiting - verified April 2015

SONOlysis in Prevention of Brain InfaRctions During Internal Carotid Endarterectomy

Condition:   Internal Carotid Artery Stenosis
Intervention:   Device: sonolysis
Sponsors:   University Hospital Ostrava;   Military University Hospital, Prague;   Vitkovice Hospital, Ostrava;   Masaryk Hospital, Usti nad Labem;   České Budějovice Hospital;   University Hospital Hradec Kralove;   University Hospital Plzen, Plzen;   County Hospital Liberec, Liberec
Not yet recruiting - verified April 2015

Vascular Ultrasound Screening in Patients With Ischemic Cerebrovascular Disease: a Multi-center Registry Study

Condition:   Stroke
Sponsors:   Xuanwu Hospital, Beijing;   The First Affiliated Hospital of Shanxi Medical University;   Liaocheng Brains Hospital;   Tianjin Huanhu Hospital;   Baotou City Central Hospital;   First Hospital of Jilin University;   First Affiliated Hospital of Harbin Medical University;   First Hospital of China Medical University;   LanZhou University;   First Affiliated Hospital of Xinjiang Medical University;   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School;   The First Affiliated Hospital of Soochow University;   Anhui Provincial Hospital;   Guangdong Provincial Hospital of Traditional Chinese Medicine;   Zhuhai  People's Hospital;   Fujian Provincial Hospital;   Mianyang Central Hospital;   The Second Affiliated Hospital of Kunming Medical University;   Brains Hospital of Hunan Province;   Henan Provincial Hospital;   Luoyang Central Hospital Affiliated to Zhengzhou University;   National Health and Family Planning Commission Stroke Prevention Engineering Committee
Not yet recruiting - verified March 2015

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease

Conditions:   Myocardial Infarction;   Ischemic Stroke;   Stroke;   Subarachnoid Haemorrhage;   Venous Thrombosis;   Transient Ischemic Attack;   Stable Angina Pectoris;   Unstable Angina;   Heart Failure;   Peripheral Arterial Disease;   Abdominal Aortic Aneurysm
Intervention:   Other: No intervention
Sponsors:   University College, London;   Wellcome Trust;   National Institute for Health Research, United Kingdom
Active, not recruiting - verified April 2015

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]

Conditions:   Acute Ischaemic Stroke;   Transient Ischaemic Attack.
Interventions:   Drug: ticagrelor;   Drug: Acetylsalicylic acid (ASA)
Sponsor:   AstraZeneca
Recruiting - verified April 2015

ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial

Condition:   Peripheral Endovascular Interventions
Intervention:   Drug: Bivalirudin
Sponsor:   The Medicines Company
Recruiting - verified July 2014

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

Conditions:   Stroke,;   Embolism
Intervention:   Other: Rivaroxaban ( Xarelto, BAY59-7939)
Sponsor:   Bayer
Recruiting - verified April 2015

Nutrition Blood Outcomes Following Tocotrienol N2B

Condition:   Stroke
Interventions:   Dietary Supplement: Tocotrienol Capsules;   Other: Placebo Vehicle
Sponsors:   Ohio State University;   Malaysian Palm Oil Board
Recruiting - verified April 2015

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event

Conditions:   Ischemic Stroke;   Transient Ischemic Attack (TIA)
Interventions:   Other: Vitamin E tocotrienol (TCT) capsules ; Low dose Aspirin;   Other: Placebo vehicle control
Sponsors:   Chandan K Sen;   Government of Malaysia
Recruiting - verified April 2015

Role of Cerebral Oximetry In Reducing Delirium After Complex Cardiac Surgery

Condition:   Cardiac Disease
Interventions:   Device: Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter);   Other: An alarm threshold at 75% of the baseline rSO2 value
Sponsor:   University Health Network, Toronto
Active, not recruiting - verified April 2015

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial

Conditions:   Stroke;   Transient Ischemic Attack
Interventions:   Behavioral: tailored intervention;   Behavioral: attention placebo
Sponsor:   Narrows Institute for Biomedical Research
Completed - verified April 2015

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Condition:   Ischemic Attack, Transient
Interventions:   Drug: Clopidogrel;   Drug: placebo
Sponsors:   University of California, San Francisco;   Neurological Emergencies Treatment Trials Network (NETT);   Medical University of South Carolina;   The EMMES Corporation
Recruiting - verified April 2015

Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease

Conditions:   Cerebrovascular Disorders;   Smoking Cessation
Interventions:   Drug: Cost-Free Pharmacotherapy Group;   Other: Prescription Only Group
Sponsors:   Ottawa Heart Institute Research Corporation;   Heart and Stroke Foundation of Ontario
Completed - verified April 2015

Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack

Conditions:   Ischemic Stroke;   Transient Ischemic Attacks
Interventions:   Drug: Antihypertensive agents and lipid lowering therapy;   Other: Usual Care
Sponsors:   University of Alberta;   Heart and Stroke Foundation of Canada;   Alberta Heritage Foundation for Medical Research
Completed - verified April 2015

Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke

Condition:   Cardiovascular Disease
Intervention:   Drug: atorvastatin
Sponsor:   Pfizer
Completed - verified April 2015

Get CardioSmart

You're Invited